Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Enfusion (NYSE:ENFN) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 1 | 2 | 1 |
| Last 30D | 0 | 0 | 0 | 1 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 1 |
| 2M Ago | 0 | 0 | 0 | 1 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Enfusion, presenting an average target of $9.0, a high estimate of $10.00, and a low estimate of $8.00. A decline of 2.7% from the prior average price target is evident in the current average.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how...
ログインすると全部閲覧できます。
ログイン